| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Keisuke Suzuki CEO | JPX Exchange | JP3754500001 ISIN |
| Japan Country | 1,250 Employees | 29 Sep 2026 Last Dividend | 27 Dec 2017 Last Split | - IPO Date |
Japan Lifeline Co., Ltd. is a pioneering medical device company established in 1981, with its headquarters situated in Tokyo, Japan. The company is deeply invested in the development, production, importation, distribution, and trading of a wide variety of medical devices, with a special focus on those meant for cardiovascular care. Known for its innovative approach in the medical field, Japan Lifeline Co., Ltd. has built a reputation for delivering high-quality, reliable heart-related medical solutions across Japan, catering to the intricate needs of patients and healthcare providers in the cardiovascular domain.
These include a range of devices designed to manage heart rhythm disorders effectively. The product lineup features cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices. Each device plays a critical role in offering lifesaving treatments for patients with arrhythmias and other heart rhythm disorders.
This category encompasses electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. These products are essential for diagnosing and treating heart rhythm conditions with precision and efficacy.
The product range includes vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems. These are vital for treating various blood vessel conditions and are indispensable in surgeries to repair damaged or weakened areas in the artery wall.
In this category, the company offers PTCA (Percutaneous Transluminal Coronary Angioplasty) and PTA (Percutaneous Transluminal Angioplasty) guide wires, and PTCA balloon catheters. These devices are crucial for opening narrowed or blocked arteries to restore normal blood flow to the heart and other parts of the body.
Japan Lifeline Co., Ltd. extends its expertise to the realm of gastrointestinal interventions with products like cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems. These tools are essential for diagnosing and managing gastrointestinal diseases.
Including products such as radiofrequency wires and atrial septal defect closure devices. These are indispensable in non-invasive surgeries aimed at correcting structural heart diseases, offering patients safer and less intrusive treatment options.
The company also provides solutions for neurovascular interventions. These innovative medical devices play a significant role in treating conditions related to the veins and arteries that supply the brain, further showcasing Japan Lifeline Co., Ltd.'s commitment to addressing a comprehensive range of cardiovascular and related health conditions.